(marketscreener.com) Modulus Discovery, Inc. (CEO: S. Roy Kimura, Ph.D., "Modulus"), an early stage global biopharmaceutical company, announced today the signing of research data transfer agreement on a specific drug target with Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., ...http://www.marketscreener.com/news/Modulus-Discovery-Announces-Signing-of-Research-Data-Transfer-Agreement-with-Astellas-Pharma-Inc--28680517/?utm_medium=RSS&utm_content=20190530
Modulus Discovery is a Japan-based drug discovery company that develops and commercializes small-molecule therapies for the treatment of cancer and inflammatory diseases.